Loading…

bioMérieux agreed to acquire 100% of SpinChip Diagnostics for a total enterprise value of NOK 1,624 million (EUR 138 million), strengthening its position in the Point of Care diagnostics market.
“The acquisition of SpinChip is very promising for bioMérieux and fully consistent with our GO•28 strategic plan agenda.”spinchip.no
Summarized from public sources; check the original articles before acting on it.